ERBB2 and breast carcinoma: Another was able to identify a population of EpCAM-negative CTCs isolated from the peripheral blood of breast cancer patients with a unique signature of HER2+/EGFR+/HPSE+/Notch1+ that was then able to generate brain metastases in nude mice as a xenograft, serving as a proof of concept [68].